Nandrolone: A Multi-Faceted Doping Agent
Publication type: Book Chapter
Publication date: 2009-11-05
scimago Q1
SJR: 1.080
CiteScore: 6.6
Impact factor: —
ISSN: 01712004, 18650325
PubMed ID:
20020363
Abstract
Nandrolone or nortestosterone, an anabolic-androgenic steroid, has been prohibited by doping control regulations for more than 30 years. Although its main metabolism in the human body was already known at that time, and detection of its misuse by gas or liquid chromatographic separation with mass spectrometric detection is straightforward, many interesting aspects regarding this doping agent have appeared since. Over the years, nandrolone preparations have kept their position among the prohibited substances that are most frequently detected in WADA-accredited laboratories. Their forms of application range from injectable fatty acid esters to orally administered nandrolone prohormones. The long detection window for nandrolone ester preparations and the appearance of orally available nandrolone precursors have changed the pattern of misuse. At the same time, more refined analytical methods with lowered detection limits led to new insights into the pharmacology of nandrolone and revelation of its natural production in the body. Possible contamination of nutritional supplements with nandrolone precursors, interference of nandrolone metabolism by other drugs and rarely occurring critical changes during storage of urine samples have to be taken into consideration when interpreting an analytical finding. A set of strict identification criteria, including a threshold limit, is applied to judge correctly an analytical finding of nandrolone metabolites. The possible influence of interfering drugs, urine storage or natural production is taken into account by applying appropriate rules and regulations.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
Drug Testing and Analysis
3 publications, 25%
|
|
|
Experimental and Therapeutic Medicine
1 publication, 8.33%
|
|
|
Materials
1 publication, 8.33%
|
|
|
Molecular and Cellular Neurosciences
1 publication, 8.33%
|
|
|
Neuroscience Letters
1 publication, 8.33%
|
|
|
Andrologia
1 publication, 8.33%
|
|
|
Archives of Physiology and Biochemistry
1 publication, 8.33%
|
|
|
Macromolecules
1 publication, 8.33%
|
|
|
Journal of Industrial and Engineering Chemistry
1 publication, 8.33%
|
|
|
1
2
3
|
Publishers
|
1
2
3
4
5
|
|
|
Wiley
5 publications, 41.67%
|
|
|
Elsevier
3 publications, 25%
|
|
|
Spandidos Publications
1 publication, 8.33%
|
|
|
MDPI
1 publication, 8.33%
|
|
|
Taylor & Francis
1 publication, 8.33%
|
|
|
American Chemical Society (ACS)
1 publication, 8.33%
|
|
|
1
2
3
4
5
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
12
Total citations:
12
Citations from 2024:
4
(33.34%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Hemmersbach P. Nandrolone: A Multi-Faceted Doping Agent // Handbook of Experimental Pharmacology. 2009. Vol. 195. pp. 127-154.
GOST all authors (up to 50)
Copy
Hemmersbach P. Nandrolone: A Multi-Faceted Doping Agent // Handbook of Experimental Pharmacology. 2009. Vol. 195. pp. 127-154.
Cite this
RIS
Copy
TY - GENERIC
DO - 10.1007/978-3-540-79088-4_6
UR - https://doi.org/10.1007/978-3-540-79088-4_6
TI - Nandrolone: A Multi-Faceted Doping Agent
T2 - Handbook of Experimental Pharmacology
AU - Hemmersbach, Peter
PY - 2009
DA - 2009/11/05
PB - Springer Nature
SP - 127-154
IS - 195
PMID - 20020363
SN - 0171-2004
SN - 1865-0325
ER -
Cite this
BibTex (up to 50 authors)
Copy
@incollection{2009_Hemmersbach,
author = {Peter Hemmersbach},
title = {Nandrolone: A Multi-Faceted Doping Agent},
publisher = {Springer Nature},
year = {2009},
number = {195},
pages = {127--154},
month = {nov}
}